Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Chuan Liu has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner and 1 distinct art unit, indicating a single point of prosecution for the current portfolio activity. This focused approach suggests that the applicant is currently concentrating on the Biotechnology & Pharmaceuticals field.
The busiest examiner, HASSAN, LIBAN M, is responsible for 1 busiest examiner pending action. Since this represents the only 1 pending office action for the applicant, the progress of the portfolio is currently determined by the examination pace and decisions of this 1 distinct examiner. To advance the matter, it is crucial to understand the specific examination trends and requirements of this individual. The lack of diversity in the 1 distinct art unit for the current workload means that the applicant's immediate patenting success is tied to the administrative path at the patent office.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HASSAN, LIBAN M | 1 | 50.8% | +31.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18216504 | FRACTAL CUES SUPPORT HIERARCHICAL MATURATION OF CELLS VIA CURVATURE-INDUCED PATTERNING | HASSAN, LIBAN M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18216504 | FRACTAL CUES SUPPORT HIERARCHICAL MATURATION OF CELLS VIA CURVATURE-INDUCED PATTERNING | HASSAN, LIBAN M | — |
| Art Unit | Apps |
|---|---|
| 1634 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18216504 | FRACTAL CUES SUPPORT HIERARCHICAL MATURATION OF CELLS VIA CURVATURE-INDUCED PATTERNING | HASSAN, LIBAN M | 1634 | §102§103§112 | Non-Final OA | — | Pending | Jun 29, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialChuan Liu has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Liban M Hassan has the most, with 1 of Chuan Liu's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
